Health Services Company Announces $103 Million Business Combination

TRxADE HEALTH, INC. (Nasdaq: MEDS), a company recognized for its innovative approach to pharmaceutical distribution, and Scienture, Inc., an emerging specialty pharmaceutical company, have announced the closing of their business combination in a significant all-stock transaction valued at approximately $103 million. This merger brings together TRxADE’s robust distribution capabilities with Scienture’s cutting-edge product portfolio. The transaction involved TRxADE acquiring all of Scienture’s assets in exchange for shares of TRxADE stock, which include both common stock and non-voting convertible preferred stock. $Trxade Health(MEDS.US)$